Mandate

Vinge represents Lassie AB in a capital raising of SEK 260 million

November 29, 2023 M&A

Vinge has advised the pet insurance broker Lassie AB in connection with a capital raising of SEK 260 million in order to continue the expansion of the business.

Lassie AB, whose business model is based on users reducing their insurance costs by collecting points through preventive animal care, was founded by Hedda Båverud Olsson, Johan Jönsson and Sophie Wilkinson and the company has grown rapidly since the first capital round just over two years ago.

The capital round, which was led by the British venture capital firm Balderton Capital, also involved a number of existing investors, including the institutional investors Felix Capital, Inventure and Passion Capital.

Vinge's team consisted of Filip Öhrner and Tim Axell.

Related

Vinge advises OsteoCentric on the public offer for Integrum

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025